Homologous recombination deficiency as prognostic marker in metastatic gastric cancer.

N. Sousa,C. Faustino,Lucia Maria Nunes Aguas,João Freire,Camila Coutinho,Ilda Faustino,Andreia Capela,Telma Costa,Andreia Sofia Alves Costa,Sara Coelho,Filipa Pereira,Sofia Coelho Abreu,Ana Sofia Rolo,André Albergaria,Jorge Lima,Xiaogang Wen,Carina Mesquita,Claudia Camila-Dias,Luís Azevedo,Fátima Carneiro

Homologous recombination deficiency as prognostic marker in metastatic gastric cancer.

2019

4040Background: Gastric cancer is the 5th cancer diagnosis and 3rd cause of cancer death worldwide. Metastatic gastric cancer (mGC) has a median survival of 11 months. mGC is an heterogeneous disea...

Keywords:

Metastatic gastric cancer
Homologous Recombination Deficiency
Pathology
Cancer research
Medicine
median survival
Internal medicine
Cancer
Oncology
cancer death

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations